MARS-2 now The Lancet Respiratory Medicine, Dr Eric Lim et al. Phase 3 trial of extended pleurectomy decortication then chemo vs chemo alone in pleural #mesothelioma . Survival 19.3m with surgery and 24.8m with no surgery. Surgery arm also had more serious adverse events.
thelancet.com/journals/lanre…

Students, Fellows and Early Career attendees at #asco24 - make sure to check out these opportunities offered in a lounge space dedicated to you! ⁦ASCO⁩ ⁦Mandy Davis Aitken⁩ connection.asco.org/tec/career/pro…

Concurrent immunotherapy (+ chemo) with standard radiation is not a viable approach in nsclc, now a second negative phase 3 trial after pacific 2 #lcsm news.bms.com/news/corporate…

Yesss so excited to see everyone! Come join ASCO OncMedEdCoP Sat June 1st 7:30-9:30 am for #meded networking and an awesome talk by our friend Julia Close, MD, MBA! See you ASCO! 🥰

Awesome way to start your Saturday at #ASCO24 ! Come join in the fun! #OncMedEd #MedEd

Super pumped to share details for our MedEd CoP #ASCO24 Annual Meeting session. June 1, 7:30-9:30am! 🥁 Featuring Keynote Address by the incomparable Julia Close, MD, MBA, updates on collaboration initiatives from our #Scholarship committee, and #MedEd networking! Full agenda below 👇

US FDA accepts for priority review BLA of zenocutuzumab (HER2/3 bispecific antibody) for patients with #NRG1 fusion NSCLC or pancreatic cancer. Fusions in NRG1 (neuregulin) are rare but important, can be missed by DNA NGS, best detected with RNA-seq.

ir.merus.nl/news-releases/…

Trainee & Early Career Oncologists:

Sessions and networking events for #ASCO24 ASCO are here!!!⬇️

Plan in advanced and get a ☕️ at the new, larger location of the ASCOTECAG lounge! (Hall C)

society.asco.org/sites/new-www.…

Jacob J. Adashek, DO Fernando Diaz, MD Aakash Desai, MD, MPH

Coming soon! Join us for our next CoP virtual Town Hall: Mon 5/20 @ 5pm EST. Get updates on mentorship, scholarship opportunities, and #MedEd sessions at the #ASCO24 annual meeting. Zoom link available on our ASCO Connection events page! #OncMedEd Maria Baggstrom MD FACP Kristen A. Marrone, MD

Share your voice to FDA Oncology's Project 5 in 5 crowdsourcing initiative - seeking ideas to identify 5 clinically relevant questions using FDA-approved oncology therapies that can be answered through pragmatic clinical trials over the next 5 years. shareyourvoice.ideascalegov.com

⏰NOW OUT‼️ #ASCO24 🔥Educational Book #LCSM
✅New Tx Options for Oncogene-Addicted NSCLC Focusing on EGFR-Mutant Tumors
🎙️Stephanie Saw Xiuning Le MD PhD Lizza Hendriks Jordi Remon
✅NSCLC Metastatic Without Oncogenic Alterations
🎙️Dr. Nikolaj Frost Martin Reck
OncoAlert ASCO

1/ 🔥Our 🆕 Clinical Lung Cancer Brief Report on 1L testing & management in mNSCLC is out! With multiple frontline treatments, it's a complex landscape!

Enjoyed collaborating w/ mentee Arthi Sridhar & mentor H. Jack West, MD.

Key insights👇🏽, a 🧵: ⁦OncoAlert⁩ sciencedirect.com/science/articl…

Hot of the Press: A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer | Advances in Therapy link.springer.com/article/10.100…

#ASCO24 is 4 weeks away! Excited to dive into key studies and their clinical impact at Advancements in Oncology!

InPerson: June 1st, 2024 with Margaret Gatti-Mays MD MPH FACP Dr. Cathy Eng Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation Karine Tawagi MD we will navigate our changing Rx Landscape!

Register: [email protected]…

Dear Students, Trainees, and Early-Career Oncologists,

We put together these tips to advice on how to plan your ASCO annual meeting!

⭐️ Grow professionally and have fun!

ASCO ASCOTECAG ASCOPres Jacob J. Adashek, DO Cissa Mathias #ASCOConnection

Breaking news from the #ASCOPlenarySeries : Glecirasib demonstrates encouraging efficacy and safety in KRASG12C-mutated #NSCLC in phase 2 trial from China. #ASCODailyNews has more: brnw.ch/21wJkJ4

Latest from #ASCOPlenarySeries : Glecirasib Shows Promise in Treating Patients w/ #NSCLC w/ KRAS G12C Mutation

📅 Live presentation tomorrow, 4/30, at 3 PM ET
Panel: Drs. Melissa L. Johnson, Yuankai Shi, Stephen V Liu, MD, Julia Rotow MD

Abstract: brnw.ch/21wJiEh #LCSM @oncoalert

A glimpse of many exciting Med Ed & Professional Dev abstracts to be presented at the ASCO Annual Meeting this year, including 1 oral & 3 posters from our collaboration btw TwoOncDocs & The Fellow On Call

Ronak H. Mistry, DO Samantha Armstrong Karine Tawagi MD Vivek Patel, MD Daniel Hausrath

Non–Small Cell Lung Cancer Metastatic Without Oncogenic Alterations | American Society of Clinical Oncology Educational Book ascopubs.org/doi/10.1200/ED… #ASCO24 #LCSM Martin Reck

Lung 🫁 taking the lead at ASCO 24 with 3 plenaries !!